Mutual Pharmaceuticals: 1 Issuer's and Sponsors' Responses to the Second Round of Review Enquiry Letter (Revised Draft)

SZSI · Aug 8, 2022 00:00

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.